Literature DB >> 19958117

Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients.

Julia Beutel1, Jürgen Wegner, Rayime Wegner, Focke Ziemssen, Khaled Nassar, Jens Martin Rohrbach, Ralf-Dieter Hilgers, Matthias Lüke, Salvatore Grisanti.   

Abstract

PURPOSE: To evaluate the expression of melanoma cell adhesion molecule (MCAM) as prognostic factor in uveal melanoma patients.
METHODS: Paraffin sections from 35 primary uveal melanomas were analyzed immunhistochemically for the expression of MCAM. Further known prognostic factors such as cell type, ciliary body invasion, tumor stage, and local extension were evaluated. In 16 cases, patients had developed metastatic disease. The patients without metastasis (n = 19) had a mean follow-up of 10.6 (9-13) years.
RESULTS: All tumors were positive for MCAM (mean: 57.05%). In the group without metastasis, an average MCAM expression of 35.37% (SD 19.66%) compared to 82.78% (SD 11.73%) in the metastasis group was found. The Cox regression analysis showed a significant association of an enhanced MCAM expression and death due to metastasis (HR: 365.48, 95% CI: 18.51, 7217.85).
CONCLUSION: MCAM expression of primary uveal melanomas can serve as a possible prognostic parameter for metastasis. If further experiments approve the cellular adhesion molecules to account for early micrometastasis of tumor cells, a possible target might be available for future treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19958117     DOI: 10.3109/02713680903262205

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  2 in total

Review 1.  Proteomics of uveal melanoma: a minireview.

Authors:  Søren K O Abildgaard; Henrik Vorum
Journal:  J Oncol       Date:  2013-09-03       Impact factor: 4.375

2.  Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture.

Authors:  Aaron B Beasley; Timothy W Isaacs; Tersia Vermeulen; James Freeman; Jean-Louis DeSousa; Riyaz Bhikoo; Doireann Hennessy; Anna Reid; Fred K Chen; Jacqueline Bentel; Daniel McKay; R Max Conway; Michelle R Pereira; Bob Mirzai; Leslie Calapre; Wendy N Erber; Melanie R Ziman; Elin S Gray
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.